Olanzapine and Samidorphan L-Malate
LYBALVI
Atypical Antipsychotic
NADAC/unit
$55.0315
No Shortage
Tier 1: 47.4%
PA Req: 122.8%
Olanzapine and Samidorphan L-Malate treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
vs. brand LYBALVI: Generic saves up to -450% per unit
Generic Manufacturers
ALKERMES INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.